Parallel Advisors, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$17.71 - $32.97 $106 - $197	6 New	6 $0
Q4 2022 Feb 03, 2023	SELL	$14.14 - $23.06 $240 - $392	-17 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$17.64 - $39.57 $1,023 - $2,295	-58 Reduced 77.33%	17 $0
Q4 2021 Jan 20, 2022	BUY	$34.2 - $47.56 $1,607 - $2,235	47 Added 167.86%	75 $3,000
Q3 2021 Nov 02, 2021	BUY	$27.88 - $58.25 $223 - $466	8 Added 40.0%	28 $1,000
Q1 2021 Apr 23, 2021	BUY	$38.75 - $86.92 $775 - $1,738	20 New	20 $1,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.